I

Ipsen Global

Global biopharma focused on specialty care

Program Manager - New Product Introduction & Commercial Readiness

Program ManagementPosted on Nov 5
Full-timeWrexham, UKNo salary listedIn-person

About the Job

Requirements

  • Previous experience as a Program or Project Manager leading new product introduction or commercial readiness programs or projects in the pharmaceutical manufacturing industry.
  • Experience with technology and/or facility transfer.
  • PMP or PRINCE2 certification.
  • Ability to drive programs forward in a fast-paced environment, balance multiple priorities, and proactively engage stakeholders and project teams to deliver successful outcomes.

Responsibilities

  • Lead end-to-end New Product Introduction and commercial readiness programs from development through commercial launch.
  • Develop and execute program plans, ensuring delivery against timelines, milestones, budgets, and business objectives.
  • Drive commercial readiness activities, including capacity planning, resource allocation, and facility preparedness for commercial-scale manufacturing.
  • Identify, assess, and mitigate program risks to ensure successful project outcomes.
  • Lead and influence cross-functional teams, fostering collaboration and alignment across key stakeholders.
  • Monitor program performance, drive continuous improvement initiatives, and ensure compliance with quality and regulatory standards.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs